{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-045006","form_type":"8-K","ticker":"HOOK","cik":"0001760542","company_name":"HOOKIPA Pharma Inc.","filed_at":"2023-04-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.430529+00:00","generated_at":"2026-06-17T02:43:43.941386+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Director Michael A. Kelly resigns; Board adopts 2023 Inducement Plan reserving 500,000 shares","bullets":["Director Michael A. Kelly resigned effective April 7, 2023, not due to any disagreement with the Company.","Terry Coelho appointed Chair of Audit Committee to fill vacancy; deemed audit committee financial expert.","Board approved 2023 Inducement Plan reserving 500,000 shares of common stock for new employee inducement grants.","Awards under the plan limited to employees commencing employment, per Nasdaq Rule 5635(c)(4)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-045006","json":"https://secwatch.observer/filing/0001104659-23-045006.json","markdown":"https://secwatch.observer/filing/0001104659-23-045006.md","text":"https://secwatch.observer/filing/0001104659-23-045006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760542/000110465923045006/0001104659-23-045006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760542/000110465923045006/tm2312420d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T02:43:43.941386+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"37c71ebf63","claim":"Michael A. Kelly resigned as Director at HOOKIPA Pharma Inc..","evidence_excerpt":"On April 7, 2023, Michael A. Kelly, a member of the Board, notified the Company of his resignation from the Board, including the Audit Committee of the Board (the “Audit Committee”), on which he serves as the Chair and a member and the Compensation Committee of the Board on which he serves as a member, effective April 7, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465923045006/0001104659-23-045006-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}